News

Biochemist Svetlana Mojsov, honored for GLP-1 research that has transformed metabolic disease care, says she’s grateful to ...
Tel Aviv University and Sheba Medical Center scientists say their bioengineered skin can double the healing speed for skin ...
Tevogen ('Tevogen Bio Holdings Inc.” or 'Company”) (Nasdaq: TVGN) announced today that the International Bureau of the World ...
The study of ferrocene-based peptides has emerged as a vibrant interdisciplinary field, bridging organometallic chemistry, peptide science and materials research. Ferrocene, with its robust ...
Glucagon-like peptide 1 receptor agonists may offer neuroprotective and survival benefits beyond blood sugar control.
Shedding is perfectly normal, but when it starts happening more quickly and in higher quantities, there may be other factors ...
A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists ...
GLP-1 receptor agonists such as semaglutide and liraglutide promote significant weight loss and improved glycemic control, ...
The U.S. Food & Drug Administration has granted orphan drug designation to Chicago-based Amphix Bio's treatment for acute ...